Cargando…

Dyslipidemia and non-small cell lung cancer risk in Chinese population: a case-control study

BACKGROUND: Numerous studies reported that dyslipidemia was associated with cancer risk. However, few studies investigated the associations between dyslipidemia and non-small cell lung cancer (NSCLC). METHODS: Four hundred twenty-four histologically confirmed NSCLC cases and 414 controls, matched fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Bo, Yu, Miaomei, Sang, Chen, Bi, Baochen, Chen, Jiajun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284307/ https://www.ncbi.nlm.nih.gov/pubmed/30522496 http://dx.doi.org/10.1186/s12944-018-0925-z

Ejemplares similares

Role of TLR4 as a prognostic factor for survival in various cancers: a meta-analysis
por: Hao, Bo, et al.
Publicado: (2018)

Dietary Branched-Chain Amino Acids (BCAAs) and Risk of Dyslipidemia in a Chinese Population
por: Yu, Lianlong, et al.
Publicado: (2022)

Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study
por: Liu, Xiaotian, et al.
Publicado: (2018)

Methylenetetrahydrofolate reductase tagging polymorphisms are associated with risk of non-small cell lung cancer in eastern Chinese Han population
por: Ding, Hao, et al.
Publicado: (2017)

Prevalence and Associated Factors of Dyslipidemia in the Adult Chinese Population
por: Wang, Shuang, et al.
Publicado: (2011)

Association of NCOA3 polymorphisms with Dyslipidemia in the Chinese Han population
por: Yu, Mingxi, et al.
Publicado: (2015)

Association of BTLA Polymorphisms with Susceptibility to Non-Small-Cell Lung Cancer in the Chinese Population
por: Wang, Jusi, et al.
Publicado: (2021)

Selenium Level and Dyslipidemia in Rural Elderly Chinese
por: Su, Liqin, et al.
Publicado: (2015)

PPAR α and PPAR γ Polymorphisms as risk factors for Dyslipidemia in a Chinese han population
por: Gu, Shu-Jun, et al.
Publicado: (2014)

Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population
por: Liu, Chiu-Shong, et al.
Publicado: (2010)

Association between combined exposure to plasma heavy metals and dyslipidemia in a chinese population
por: Luo, Tingyu, et al.
Publicado: (2022)

Association of ERBB4 genetic polymorphism with the risk and prognosis of non-small cell lung cancer in Chinese Han population: A population-based case–control study
por: Wang, Wan-ping, et al.
Publicado: (2021)

Dyslipidemia and Eye Diseases in the Adult Chinese Population: The Beijing Eye Study
por: Wang, Shuang, et al.
Publicado: (2012)

Evaluation of Task fMRI Decoding With Deep Learning on a Small Sample Dataset
por: Yotsutsuji, Sunao, et al.
Publicado: (2021)

Is long-term PM(1) exposure associated with blood lipids and dyslipidemias in a Chinese rural population?
por: Mao, Shuyuan, et al.
Publicado: (2020)

Prevalence, awareness, treatment, and control of dyslipidemia in Chinese adults: a systematic review and meta-analysis
por: Xia, Qianhang, et al.
Publicado: (2023)

Association Between Triglyceride Glucose Index and Non-Small Cell Lung Cancer Risk in Chinese Population
por: Yan, Xin, et al.
Publicado: (2021)

Time series decomposition into dyslipidemia prevalence among urban Chinese population: secular and seasonal trends
por: Lao, Jiahui, et al.
Publicado: (2021)

Female exposed to the Chinese famine increases the risk of dyslipidemia in later life
por: Xiong, Huali, et al.
Publicado: (2023)

Comparison of dyslipidemia incidence in Chinese early-stage breast cancer patients following different endocrine therapies: A population-based cohort study
por: Wang, Junren, et al.
Publicado: (2022)

Favorable Genotypes of Type III Interferon Confer Risk of Dyslipidemia in the Population With Obesity
por: Xu, Tiantian, et al.
Publicado: (2022)

Chinese Herbal Medicine on Dyslipidemia: Progress and Perspective
por: Guo, Ming, et al.
Publicado: (2014)

2016 Chinese guidelines for the management of dyslipidemia in adults
Publicado: (2018)

Interleukin-27 rs153109 polymorphism and the risk of non-small-cell lung cancer in a Chinese population
por: Ge, Peng, et al.
Publicado: (2016)

Dyslipidemia Risk in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study
por: Song, Youhyun, et al.
Publicado: (2022)

Dyslipidemia and cardiovascular disease risk among the MASHAD study population
por: Hedayatnia, Mahshad, et al.
Publicado: (2020)

The Prognostic Value of Biomarkers on Detecting Non-Small Cell Lung Cancer in a Chinese Elderly Population
por: Guo, Lianghua, et al.
Publicado: (2021)

High prevalence of dyslipidemia and associated risk factors among rural Chinese adults
por: Sun, Guo-Zhe, et al.
Publicado: (2014)

The positive association of branched-chain amino acids and metabolic dyslipidemia in Chinese Han population
por: Yang, Panpan, et al.
Publicado: (2016)

Association of KCTD10, MVK, and MMAB polymorphisms with dyslipidemia and coronary heart disease in Han Chinese population
por: Sun, Jie, et al.
Publicado: (2016)

Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control
por: Huang, Yuanxiu, et al.
Publicado: (2014)

Dyslipidemia Increases the Risk of Incident Hypertension in a Large Taiwanese Population Follow-Up Study
por: Lin, Yu-Hsuan, et al.
Publicado: (2022)

The interleukin-18 gene promoter -607 A/C polymorphism contributes to non-small-cell lung cancer risk in a Chinese population
por: Jia, Youchao, et al.
Publicado: (2016)

A Functional Polymorphism in Accessible Chromatin Region Confers Risk of Non-Small Cell Lung Cancer in Chinese Population
por: Long, Jieyi, et al.
Publicado: (2021)

SNPs in LncRNA genes are associated with non‐small cell lung cancer in a Chinese population
por: Wang, Ruoyang, et al.
Publicado: (2019)

Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2020)

Updates in Small Interfering RNA for the Treatment of Dyslipidemias
por: Carugo, S., et al.
Publicado: (2023)

Dyslipidemia Might Be Associated with an Increased Risk of Osteoarthritis
por: Xiong, Jianping, et al.
Publicado: (2020)

The Evaluation of Chinese Therapeutic Food for the Treatment of Moderate Dyslipidemia
por: Sun, Shu, et al.
Publicado: (2012)

Association of dietary cholesterol and dyslipidemia in Chinese health examinees
por: Pan, Junqiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m5s1c0n0oqga04in1ef63eojr5